Form 4: Elanco Animal Health CEO Jeffrey N. Simmons Reports Acquisition of Deferred Stock Units

Sentiment:

SEC Form 4 Filing


Elanco Animal Health's CEO, Jeffrey N. Simmons, reported the acquisition of deferred stock units on November 1, 2024.

Summary

  • On November 1, 2024, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired 219.781 deferred stock units.
  • These deferred stock units represent the right to receive one share of Elanco's common stock or the cash equivalent.
  • Following the transaction, Simmons directly owns 4,126.3312 shares of Elanco common stock.
  • The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of stock units by the CEO could be interpreted as a slightly positive signal, but it's primarily an informational filing.

Positives

  • The acquisition of deferred stock units by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

Executive compensation in the animal health industry often includes stock-based awards to align management's interests with those of shareholders. This Form 4 filing reflects such a practice at Elanco Animal Health.

Comparison to Industry Standards

  • Stock-based compensation is a common practice among publicly traded companies, including those in the animal health sector such as Zoetis and IDEXX Laboratories.
  • The specific terms of the Executive Deferral and Stock Match Plan would need to be compared to similar plans at peer companies to assess its competitiveness and alignment with industry standards.

Stakeholder Impact

  • The acquisition of deferred stock units by the CEO aligns his interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

DateDescription
11/01/2024Date of the transaction where Jeffrey N. Simmons acquired deferred stock units.
11/05/2024Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.